Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Survivin and apoptosis control.

Dario C Altieri1

  • 1Department of Cancer Biology and Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

Advances in Cancer Research
|April 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity.

Cancer research·2025
Same author

Kaposi's sarcoma-associated herpesvirus induces mitochondrial fission to evade host immune responses and promote viral production.

Nature microbiology·2025
Same author

Parkin activates innate immunity and promotes antitumor immune responses.

The Journal of clinical investigation·2025
Same author

Parkin activates innate immunity and promotes antitumor immune responses.

The Journal of clinical investigation·2024
Same author

Role of Kindlin 2 in prostate cancer.

Scientific reports·2024

Survivin, a key protein in cell division and survival, is highly expressed in human cancers but not normal tissues. Targeting this protein offers new avenues for cancer detection and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Survivin is a member of the inhibitor of apoptosis (TAP) gene family.
  • It is differentially expressed in most human cancers but not in normal tissues.
  • Survivin plays a critical role in regulating mitosis and inhibiting apoptosis.

Purpose of the Study:

  • To review current developments in survivin research.
  • To highlight survivin's role in apoptosis regulation and mitotic progression.
  • To discuss the potential of targeting the survivin pathway for cancer diagnosis and therapy.

Main Methods:

  • Literature review of survivin research.
  • Analysis of survivin's function in cell division and apoptosis.
  • Exploration of survivin's clinical applications.

Related Experiment Videos

Main Results:

  • Survivin is crucial for the viability of dividing tumor cells.
  • Its unique properties enable applications in cancer detection, diagnosis, and outcome prediction.
  • Targeting survivin may reduce cancer cell survival thresholds.

Conclusions:

  • Survivin is a promising target for novel cancer therapies.
  • Understanding survivin's pathway is key to advancing cancer diagnosis and treatment.
  • Further research into survivin holds significant potential for oncology.